Results 91 to 100 of about 19,704 (200)

Effects of ACE-inhibitors and angiotensin receptor blockers on inflammation. [PDF]

, 2012
The role of inflammation in cardiovascular disease and in hypertensive disease above all, is complex. Several studies confirm that activation of renin-angiotensin-aldosterone system (RAAS), through increase in the production of angiotensin II (Ang II ...
Buttà C, DI RAIMONDO, Domenico, LICATA, Giuseppe, Miceli S, PINTO, Antonio, TUTTOLOMONDO, Antonino   +5 more
core   +1 more source

Adaptive designs in clinical trials: why use them, and how to run and report them [PDF]

, 2018
Adaptive designs can make clinical trials more flexible by utilising results accumulating in the trial to modify the trial’s course in accordance with pre-specified rules.
Bedding, Alun W, Choodari-Oskooei, Babak, Dimairo, Munyaradzi, Flight, Laura, Hampson, Lisa V, Holmes, Jane, Jaki, Thomas, Mander, Adrian, Odondi, Lang'o, Pallmann, Philip, Sydes, Matthew R, Villar, Sofia S, Wason, James, Weir, Christopher, Wheeler, Graham M, Yap, Christina   +15 more
core   +9 more sources

Development of telmisartan in the therapy of spinal cord injury: pre-clinical study in rats

Drug Design, Development and Therapy, 2015
Chien-Min Lin,1,* Jo-Ting Tsai,2,* Chen Kuei Chang,1 Juei-Tang Cheng,3 Jia-Wei Lin11Department of Neurosurgery, 2Department of Radiation Oncology, Shuang Ho Hospital-Taipei Medical University, 3Institute of Medical Science, College of Health Science ...
Lin CM, Tsai JT, Chang CK, Cheng JT, Lin JW   +4 more
doaj  

Three spectrophotometric quantitative analysis of bisoprolol fumarate and telmisartan in fixed-dose combination utilizing ratio spectra manipulation methods

Scientific Reports
Hypertension is a chronic condition with multiple drug regimens. Limiting these medicines is critical to patient compliance. Therefore, bisoprolol and telmisartan were recently developed in a fixed-dose combination to control blood pressure.
Osama I. Abdel Sattar, Hamed H. M. Abuseada, Sherif Ramzy, Mahmoud M. Abuelwafa   +3 more
doaj   +1 more source

CHRONIC HEART FAILURE AND DIABETES MELLITUS TYPE 2: QUALITY OF LIFE AND POSSIBILITY OF ITS CORRECTION [PDF]

, 2016
Chronic heart failure of ischemic origin complicated by concomitant diabetes mellitus type 2 is characterized by significant decreasing of the quality of life in general, and of physical and psychological welfare, self-service and independence of action,
Buriak, O.G., Chympoy, C., Pavlyukovich, N., Pavlyukovich, O.   +3 more
core  

ACE inhibitors and ARBs: One or the other -- not both -- for high-risk patients [PDF]

, 2009
Avoid prescribing an angiotensin-converting enzyme (ACE) inhibitor and an angiotensin receptor blocker (ARB) for patients at high risk of vascular events or renal dysfunction.
Ewigman, Bernard, Misra, Shamita, Stevermer, James J.   +2 more
core  

Clinical use of a fixed-dose combination of telmisartan and indapamide in hypertension. Expert Council resolution

Российский кардиологический журнал
The aim of the expert council "First star duo of telmisartan and indapamide in the Russian Federation", dedicated to the introduction of a new fixed-dose combination of telmisartan and indapamide (modified-release tablets) into clinical practice was to ...
A. O. Konradi, F. T. Ageyev, A. S. Galyavich, Yu. A. Karpov, Zh. D. Kobalava, Yu. V. Kotovskaya, S. V. Nedogoda, A. O. Nedoshivin, O. N. Tkacheva   +8 more
doaj   +1 more source

Angiotensin Blockade in Patients with Diabetic Nephropathy [PDF]

, 2007
When used to delay the progression of early nephropathy in patients with type 2 diabetes mellitus, angiotensin receptor blockers (ARBs) are not superior to angiotensin-converting enzyme (ACE) inhibitors.
Jimenez, Julio, Safranek, Sarah
core  

Management of Proteinuria in Dogs and Cats with Chronic Kidney Disease [PDF]

, 2016
Atkins, Bakris, Bianchi, Bomback, Brown, Brown, Brown, Brown, Bugbee, Christ, Finco, Grauer, Grauer, Horita, Jacob, Jenkins, Jepson, Jepson, Jonathan Elliott, King, King, Laverman, Lees, Lefebvre, LeVine, Linas, Littman, Maack, McAlister, Mizutani, Nabity, Nakamura, Pollock, Pressler, Ryan, Schjoedt, Schneider, Segev, Segev, Sent, Shelly L. Vaden, Singh, Syme, Tenhundfeld, Toblli, Vaden, Wehner   +46 more
core   +2 more sources

Telmisartan is effective to ameliorate metabolic syndrome in rat model – a preclinical report

Diabetes, Metabolic Syndrome and Obesity, 2018
Kai-Chun Cheng,1,* Yingxiao Li,1,2,* Wei-Ting Chang,2,3 Feng Yu Kuo,4 Zhih-Cherng Chen,3,5 Juei-Tang Cheng2,6 1Department of Psychosomatic Internal Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima 890-8544, Japan ...
Cheng KC, Li Y, Chang WT, Kuo FY, Chen ZC, Cheng JT   +5 more
doaj